EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcatheter Aortic Valve Implantation with ACURATE neo: Results from the PROGRESS PVL Registry

Won-Keun Kim iD, Holger Thiele, Axel Linke, Thomas Kuntze, Stephan Fichtlscherer, John Webb, Michael W A Chu, Matti Adam, Gerhard Schymik, Tobias Geisler, Rajesh Kharbanda, Thomas Christen und 1 weitere

Journal of Interventional Cardiology · 25.06.2022 · 2022 · 1-10

DOI: 10.1155/2022/9138403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interventional Cardiology, erschienen am 25.06.2022. Verfasst von Won-Keun Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany. Hauptthemen laut MEDLINE: Aortic Valve Insufficiency, Aortic Valve Stenosis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The PROGRESS PVL registry evaluated transcatheter aortic valve implantation (TAVI) in patients treated with ACURATE neo, a supra-annular self-expanding bioprosthetic aortic valve.

Background

While clinical outcomes with TAVI are comparable with those achieved with surgery, residual aortic regurgitation (AR) and paravalvular leak (PVL) are common complications. The ACURATE neo valve has a pericardial sealing skirt designed to minimize PVL.

Methods

The primary endpoint was the rate of total AR over time, as assessed by a core echocardiographic laboratory. The study enrolled 500 patients (mean age: 81.8 ± 5.1 years; 61% female; mean baseline STS score: 6.0 ± 4.5%) from 22 centers in Europe and Canada; 498 patients were treated with ACURATE neo.

Results

The rate of ≥ moderate AR was 4.6% at discharge and 3.1% at 12 months; the rate of ≥ moderate PVL was 4.6% at discharge and 2.6% at 12 months. Paired analyses showed significant improvement in overall PVL between discharge and 12 months ( P < 0.001 ); 64.6% of patients had no change in PVL grade, 24.9% improved, and 10.5% worsened. Patients also exhibited significant improvement in transvalvular gradient ( P < 0.001 ) and effective orifice area ( P = 0.01 ). The mortality rate was 2.2% at 30 days and 11.3% at 12 months. The permanent pacemaker implantation (PPI) rate was 10.2% at 30 days and 12.2% at 12 months.

Conclusions

Results from PROGRESS PVL support the sustained safety and performance of TAVI with the ACURATE neo valve, showing excellent valve hemodynamics, good clinical outcomes, and significant interindividual improvement in PVL from discharge to 12-month follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve InsufficiencyAortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overAortic ValveFemaleHumansMaleProsthesis DesignRegistriesTreatment Outcome

Autor:innen und Institutionen

  • Department of Cardiology and Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany.
  • Department of Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
  • Department of Internal Medicine and Cardiology, Herzzentrum Dresden at Technische Universität Dresden, Dresden, Germany.
  • Department of Cardiology, Heart Centre, Central Clinic in Bad Berka, Bad Berka, Germany.
  • Department of Internal Medicine, Division of Cardiology, Johann W. Goethe University, Frankfurt, Germany.
  • Centre for Heart Valve Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Won-Keun Kim

Zitieren

APA

Kim, W. K., Thiele, H., Linke, A., Kuntze, T., Fichtlscherer, S., Webb, J., Chu, M. W. A., Adam, M., Schymik, G., Geisler, T., Kharbanda, R., Christen, T., & Allocco, D. (2022). Transcatheter Aortic Valve Implantation with ACURATE neo: Results from the PROGRESS PVL Registry. Journal of Interventional Cardiology, 2022, 1-10. https://doi.org/10.1155/2022/9138403

Vancouver

Kim WK, Thiele H, Linke A, Kuntze T, Fichtlscherer S, Webb J, et al. Transcatheter Aortic Valve Implantation with ACURATE neo: Results from the PROGRESS PVL Registry. Journal of Interventional Cardiology. 2022;2022:1-10. doi:10.1155/2022/9138403

BibTeX
@article{Kim2022,
  author = {Kim, Won-Keun and Thiele, Holger and Linke, Axel and Kuntze, Thomas and Fichtlscherer, Stephan and Webb, John and Chu, Michael W A and Adam, Matti and Schymik, Gerhard and Geisler, Tobias and Kharbanda, Rajesh and Christen, Thomas and Allocco, Dominic},
  title = {Transcatheter Aortic Valve Implantation with ACURATE neo: Results from the PROGRESS PVL Registry},
  journal = {Journal of Interventional Cardiology},
  year = {2022},
  volume = {2022},
  pages = {1--10},
  doi = {10.1155/2022/9138403}
}
Kostenlos starten →